VenomX

Manufacturer: Phillips Company
Effective date: 2010-09-04
Label type: HUMAN OTC DRUG LABEL
Version: 13
Source: full-release
Hydrated at: 2026-05-31 22:31:52

Label at a glance#

ProductVenomX

Active ingredientzinc acetate

Label structure13 sections

Contacts and useful links#

PhoneLabel contact580-746-2430

Label contents#

Full prescribing information#

DRUG FACTS

OTC - ACTIVE INGREDIENT SECTION

Questions and Side effects
Use of this product results in no known side effects when used according to directions. Phillips Company, 311 Chickasaw Street, Millerton, OK USA 74750; Tel. 580-746-2430
Email address: hp@valliant.net

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients Purpose
Zinc acetate (.1% by volume) Skin Protectant

ASK DOCTOR

OTC - ASK DOCTOR SECTION

Ask a doctor
If symptoms last for more than 7 days or clear up and recur within a few days.
If the conditions do not improve.
Before use on children under 2 years.
Before use if you are allergic to any ingredients listed on this label.

DO NOT USE

OTC - DO NOT USE SECTION

Warnings
For external use only
Keep away from children
Avoid contact with eyes
May be harmful if swallowed or inhaled

CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep away from children
Avoid contact with eyes
May be harmful if swallowed or inhaled

PURPOSE

OTC - PURPOSE SECTION

Active Ingredients Purpose
Zinc acetate (.1% by volume) Skin Protectant

STOP USE

OTC - STOP USE SECTION

If symptoms last for more than 7 days or clear up and recur within a few days.
If the conditions do not improve.
Before use on children under 2 years.
Before use if you are allergic to any ingredients listed on this label.

WHEN USING

OTC - WHEN USING SECTION

For external use only
Avoid contact with eyes
May be harmful if swallowed or inhaled
If symptoms last for more than 7 days or clear up and recur within a few days.
If the conditions do not improve.
Store at 40 to 120 degrees F.

WARNINGS

WARNINGS SECTION

Warnings
For external use only
Keep away from children
Avoid contact with eyes
May be harmful if swallowed or inhaled
Use of this product results in no known side effects when used according to directions.

Phillips Company, 311 Chickasaw Street, Millerton, OK USA 74750; Tel. 580-746-2430
Email address: hp@valliant.net

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Uses
Temporarily protects injured or exposed skin or mucous membrane surfaces from harmful or annoying stimuli and may help provide relief to such surfaces

Directions
Apply to affected skin area and rub gently. Repeat the process as needed.

USE

INDICATIONS & USAGE SECTION

Uses
Temporarily protects injured or exposed skin or mucous membrane surfaces from harmful or annoying stimuli and may help provide relief to such surfaces

Apply to affected skin area and rub gently. Repeat the process as needed.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Inactive ingredients
Water, color, glycerin, hydroxethylcellulose, chlor-hexidine gluconate, glucono delta lactone, methylparaben, sodium hydroxide,sodium dodecylbenzene sulfonate, dimethyl sulfoxide, witch hazel, ascorbic acid, magnesium stearate, silica and stearic acid.

Image of product

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of product

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1098625	zinc acetate 0.1 % Topical Solution	PSN	13
1098625	zinc acetate 1 MG/ML Topical Solution	SCD	13
1098625	zinc acetate 0.1 % Topical Solution	SY	13

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99	Product name	1	20250618
6c13b22c-b3ba-4127-b768-0132dd5ab0d1	Product name	1	20230829
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122
bb6d6c68-649d-4e6d-a1f6-603d969c8f68	Product name	1	20160303
190f2a5b-bbc8-65c7-fcb0-97891307b917	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
43074-207-02	2019-11-13	C162847	48780-1	97449f38-c533-f6ea-e053-dbdaa90aa703	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
43074-207-01	VenomX	3 mL in 1 BOTTLE, DROPPER	LIQUID	3		13
43074-207-02	VenomX	1 in 1 BOTTLE, PLASTIC	LIQUID	1		13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
43074-207	VENOMX (ZINC ACETATE) LIQUID [PHILLIPS COMPANY]	13	Legacy NDC, 2 package rows	20120517_1cfba647-929e-4525-b37a-b912a5a0ec4f.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
zinc acetate	ACTIVE INGREDIENT	FM5526K07A	13
zinc	ACTIVE MOIETY	J41CSQ7QDS	13
ascorbic acid	INACTIVE INGREDIENT	PQ6CK8PD0R	13
calcium gluconate	INACTIVE INGREDIENT	SQE6VB453K	13
chlorhexidine gluconate	INACTIVE INGREDIENT	MOR84MUD8E	13
dimethyl sulfoxide	INACTIVE INGREDIENT	YOW8V9698H	13
dipropylene glycol	INACTIVE INGREDIENT	E107L85C40	13
glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	13
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	13
methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	13
sodium dodecylbenzenesulfonate	INACTIVE INGREDIENT	554127163Y	13
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	13
sorbic acid	INACTIVE INGREDIENT	X045WJ989B	13
stearic acid	INACTIVE INGREDIENT	4ELV7Z65AP	13
water	INACTIVE INGREDIENT	059QF0KO0R	13
witch hazel	INACTIVE INGREDIENT	101I4J0U34	13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

VenomX
zinc acetate
zinc
dimethyl sulfoxide
ascorbic acid
dipropylene glycol
water
glycerin
chlorhexidine gluconate
calcium gluconate
methylparaben
sodium hydroxide
sorbic acid
magnesium stearate
stearic acid
witch hazel
sodium dodecylbenzenesulfonate

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
43074-207	43074-207-01, 43074-207-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
zinc acetate	FM5526K07A	ACTIM
dimethyl sulfoxide	YOW8V9698H	IACT
ascorbic acid	PQ6CK8PD0R	IACT
dipropylene glycol	E107L85C40	IACT
water	059QF0KO0R	IACT
glycerin	PDC6A3C0OX	IACT
chlorhexidine gluconate	MOR84MUD8E	IACT
calcium gluconate	SQE6VB453K	IACT
methylparaben	A2I8C7HI9T	IACT
sodium hydroxide	55X04QC32I	IACT
sorbic acid	X045WJ989B	IACT
magnesium stearate	70097M6I30	IACT
stearic acid	4ELV7Z65AP	IACT
witch hazel	101I4J0U34	IACT
sodium dodecylbenzenesulfonate	554127163Y	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 8 · 444 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
sorbic acid	SORBIC ACID	X045WJ989B	SOLUTION / OPHTHALMIC	0.2 %w/v		Exact identifier — unii candidate 19 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	JELLY / VAGINAL	NA		Exact identifier — unii candidate 75 equally ranked IID candidates
sorbic acid	SORBIC ACID	X045WJ989B	TABLET, CHEWABLE / ORAL	NA		Exact identifier — unii candidate 19 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SOLUTION/ DROPS / OPHTHALMIC		12 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRABURSAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	DISC / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR	0.35 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
stearic acid	STEARIC ACID	4ELV7Z65AP	AEROSOL, FOAM / VAGINAL	4 %w/w		Exact identifier — unii candidate 26 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION / INTRAMUSCULAR		192 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPLEURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
dipropylene glycol	DIPROPYLENE GLYCOL	E107L85C40	SYSTEM / TRANSDERMAL		6 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SPRAY / NASAL	22.3 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPERITONEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	TABLET, COATED / ORAL	0.8 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
stearic acid	STEARIC ACID	4ELV7Z65AP	EMULSION / ORAL	NA		Exact identifier — unii candidate 26 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / INTRAMUSCULAR	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / URETERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / INTRAVENOUS		45 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE, DELAYED RELEASE / ORAL		1060 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	CREAM, AUGMENTED / TOPICAL		6 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / PERINEURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	GEL / TOPICAL		7 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	SOLUTION / RESPIRATORY (INHALATION)	0.04 %w/w		Exact identifier — unii candidate 25 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	TABLET, CHEWABLE / ORAL	1.28 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IRRIGATION	2 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	TABLET, DELAYED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	GEL / TRANSDERMAL		472 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
stearic acid	STEARIC ACID	4ELV7Z65AP	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		120 mg	Exact identifier — unii candidate 26 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRACAUDAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SYSTEM / TOPICAL		42 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET, CHEWABLE, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	TABLET, COATED / ORAL	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ascorbic acid	ASCORBIC ACID	PQ6CK8PD0R	INJECTION / INTRAVENOUS		1440 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	CONCENTRATE / ORAL		12 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SYRUP / ORAL	71 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SUSPENSION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	SUSPENSION / OPHTHALMIC		58 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRADISCAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / RESPIRATORY (INHALATION)	8 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	GRANULE / ORAL		629 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
glycerin	GLYCERIN	PDC6A3C0OX	CAPSULE, EXTENDED RELEASE / ORAL		265 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	CAPSULE / ORAL	256.4 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	TABLET / BUCCAL	17.5 mg		Exact identifier — unii candidate 39 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	FILM, SOLUBLE / BUCCAL		3 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / SUBMUCOSAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
magnesium stearate	MAGNESIUM STEARATE	70097M6I30	LOZENGE / TRANSMUCOSAL		100 mg	Exact identifier — unii candidate 39 equally ranked IID candidates
methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 79 equally ranked IID candidates
sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	LIQUID / ORAL	2 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
403d2eaa-af1c-4480-9408-b038bfd3625e			1cfba647-929e-4525-b37a-b912a5a0ec4f	2010-09-04	Warnings	Exact identifier spl id: 403d2eaa-af1c-4480-9408-b038bfd3625e spl set id: 1cfba647-929e-4525-b37a-b912a5a0ec4f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.